로딩 중…
지수 로딩 중…
Pharming Group N.V.
PHAR· NASDAQ· Health Care· Pharmaceuticals, Biotechnology & Life Sciences
NL
NL$12.69+0.28%
2026-06-18
Price Chart
Pharming Group N.V.+16.91%
Financials
※ FY = Fiscal Year
Investment Metrics(as of 2026-06-18)
| Metric | Value |
|---|---|
| Size | |
| Market Cap | $896M |
| Revenue | $369M |
| Net Income | $12M |
| Total Assets | $489M |
| Net Assets | $269M |
| Value | |
| P/E | 72.69x |
| P/B | 3.33x |
| P/S | 2.43x |
| EV/EBITDA | 24.29x |
| FCF Yield | 5.59% |
| Profitability | |
| ROE | 4.58% |
| ROA | 2.52% |
| Op. Margin | 6.33% |
| Revenue Growth | -8.40% |
| Financial Health | |
| Debt Ratio | 81.95% |
| Total Debt | $116M |
| FCF | $50M |
| Cash | $53M |
| Current Ratio | 2.63x |
| Net Debt/EBITDA | 1.60x |
| Performance | |
| 1Y Return | 16.91% |
| 1M Return | 0.67% |
| From 52W High | -40.56% |
| 1Y MDD | -43.34% |
| Trading | |
| Volume | 3,216 shares |
| Trading Value | $41132.00 |
| Per Share | |
| EPS | $0.04 |
| BPS | $4.18 |